NCT00590941View on ClinicalTrials.gov

Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

July 31, 2008

Study Completion Date

April 30, 2011

Conditions
LymphomaDiffuse Large Cell
Interventions
PROCEDURE

Blood draw

Sample Collection for Genotyping prior to cycle 1 treatment of R-CHOP, if patient is enrolled after cycle 1, sample for genotyping should be collected prior to cycle 2.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT00590941 - Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma | Biotech Hunter | Biotech Hunter